|
|
||||||||
Correspondence to:
Gerald Salen
The Smith-Lemli-Opitz syndrome (SLOS) is a congenital birth defect syndrome caused by a deficiency of 3ß-hydroxysterol
These results suggest that reduced normal bile acid production is characteristic of severe SLOS phenotype and is caused not only by depletion of hepatic cholesterol but also by competitive inhibition of cholesterol 7
Supplementary key words:
7-dehydrocholesterol, 8-dehydrocholesterol
Copyright © 1999 by Lipid Research, Inc.
Original Article
Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7
Akira Hondaa,c,
Gerald Salena,b,
Sarah Shefera,
Ashok K. Battaa,
Megumi Hondaa,c,
Guorong Xua,b,
G. Stephen Tinta,b,
Yasushi Matsuzakic,
Junichi Shodac, and
Naomi Tanakac
-hydroxylase and 27-hydroxylase activities in rat liver
a Departments of Medicine and Liver Center, University of Medicine and Dentistry of New Jersey;New Jersey Medical School, Newark, NJ 07103
b Veterans Affairs Medical Center, East Orange, NJ 07018
c Department of Gastroenterology, University of Tsukuba, Tsukuba-city, Japan
7-reductase, the final enzyme in the cholesterol biosynthetic pathway. The patients have reduced plasma and tissue cholesterol concentrations with the accumulation of 7-dehydrocholesterol and 8-dehydrocholesterol. Bile acid synthesis is reduced and unnatural cholenoic and cholestenoic acids have been identified in some SLOS patients. To explore the mechanism of the abnormal bile acid production, the activities of key enzymes in classic and alternative bile acid biosynthetic pathways (microsomal cholesterol 7
-hydroxylase and mitochondrial sterol 27-hydroxylase) were measured in liver biopsy specimens from two mildly affected SLOS patients. The effects of 7- and 8-dehydrocholesterols on these two enzyme activities were studied by using liver from SLOS model rats that were treated with the
7-reductase inhibitor (BM15.766) for 4 months and were comparable with more severe SLOS phenotype in plasma and hepatic sterol compositions. In the SLOS patients, cholesterol 7
-hydroxylase and sterol 27-hydroxylase were not defective. In BM15.766-treated rats, both enzyme activities were lower than those in control rats and they were competitively inhibited by 7- and 8-dehydrocholesterols. Rat microsomal cholesterol 7
-hydroxylase did not transform 7-dehydrocholesterol or 8-dehydrocholesterol into 7
-hydroxylated sterols. In contrast, rat mitochondrial sterol 27-hydroxylase catalyzed 27-hydroxylation of 7- and 8-dehydrocholesterols, which were partially converted to 3ß-hydroxycholestadienoic acids. Addition of microsomes to the mitochondrial 27-hydroxylase assay mixture reduced 27-hydroxydehydrocholesterol concentrations, which suggested that 27-hydroxydehydrocholesterols were further metabolized by microsomal enzymes.
-hydroxylase and sterol 27-hydroxylase activities by accumulated 7- and 8-dehydrocholesterols. Unnatural bile acids are synthesized mainly by the alternative pathway via mitochondrial sterol 27-hydroxylase in SLOS.Honda, A., G. Salen, S. Shefer, A. K. Batta, M. Honda, G. Xu, G. S. Tint, Y. Matsuzaki, J. Shoda, and N. Tanaka. Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7
-hydroxylase and 27-hydroxylase activities in rat liver. J. Lipid Res. 1999. 40: 1520;1528. ![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H.-L. Liou, S. S. Dixit, S. Xu, G. S. Tint, A. M. Stock, and P. Lobel NPC2, the Protein Deficient in Niemann-Pick C2 Disease, Consists of Multiple Glycoforms That Bind a Variety of Sterols J. Biol. Chem., December 1, 2006; 281(48): 36710 - 36723. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Xu, L.-x. Pan, H. Li, Q. Shang, A. Honda, S. Shefer, J. Bollineni, Y. Matsuzaki, G. S. Tint, and G. Salen Dietary cholesterol stimulates CYP7A1 in rats because farnesoid X receptor is not activated Am J Physiol Gastrointest Liver Physiol, May 1, 2004; 286(5): G730 - G735. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Xu, H. Li, L.-x. Pan, Q. Shang, A. Honda, M. Ananthanarayanan, S. K. Erickson, B. L. Shneider, S. Shefer, J. Bollineni, et al. FXR-mediated down-regulation of CYP7A1 dominates LXR{alpha} in long-term cholesterol-fed NZW rabbits J. Lipid Res., October 1, 2003; 44(10): 1956 - 1962. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Krakowiak, C. A. Wassif, L. Kratz, D. Cozma, M. Kovarova, G. Harris, A. Grinberg, Y. Yang, A. G.W. Hunter, M. Tsokos, et al. Lathosterolosis: an inborn error of human and murine cholesterol synthesis due to lathosterol 5-desaturase deficiency Hum. Mol. Genet., July 1, 2003; 12(13): 1631 - 1641. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Onda, Y. Inoue, M. Kawabata, and T. Mita Susceptibilities of Phospholipid Vesicles Containing Different Sterols to Amphotericin B-Loaded Lysophosphatidylcholine Micelles J. Biochem., July 1, 2003; 134(1): 121 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lindenthal, T. A. Aldaghlas, J. K. Kelleher, S. M. Henkel, R. Tolba, G. Haidl, and K. von Bergmann Neutral sterols of rat epididymis: high concentrations of dehydrocholesterols in rat caput epididymidis J. Lipid Res., July 1, 2001; 42(7): 1089 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Björkhem, L. Starck, U. Andersson, D. Lütjohann, S. von Bahr, I. Pikuleva, A. Babiker, and U. Diczfalusy Oxysterols in the circulation of patients with the Smith-Lemli-Opitz syndrome: abnormal levels of 24S- and 27-hydroxycholesterol J. Lipid Res., March 1, 2001; 42(3): 366 - 371. [Abstract] [Full Text] |
||||
![]() |
A. Honda, G. Salen, Y. Matsuzaki, A. K. Batta, G. Xu, E. Leitersdorf, G. S. Tint, S. K. Erickson, N. Tanaka, and S. Shefer Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27-/- mice and CTX J. Lipid Res., February 1, 2001; 42(2): 291 - 300. [Abstract] [Full Text] |
||||
![]() |
R. D. Steiner, L. M. Linck, D. P. Flavell, D. S. Lin, and W. E. Connor Sterol balance in the Smith-Lemli-Opitz syndrome: reduction in whole body cholesterol synthesis and normal bile acid production J. Lipid Res., September 1, 2000; 41(9): 1437 - 1447. [Abstract] [Full Text] |
||||
![]() |
A. Honda, G. Salen, Y. Matsuzaki, A. K. Batta, G. Xu, E. Leitersdorf, G. S. Tint, S. K. Erickson, N. Tanaka, and S. Shefer Side Chain Hydroxylations in Bile Acid Biosynthesis Catalyzed by CYP3A Are Markedly Up-regulated in Cyp27-/- Mice but Not in Cerebrotendinous Xanthomatosis J. Biol. Chem., September 7, 2001; 276(37): 34579 - 34585. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |